Ning Zhang , Menghan Gao , Xiaolong Hu , Peng Wang , Yuan Cheng , Hui Wei , Guosheng Fu , Junbo Ge , Hongjun Li , Wenbin Zhang , Binquan Zhou
{"title":"Biomimetic peroxisome targets myocardial injury and promotes heart repair and regeneration","authors":"Ning Zhang , Menghan Gao , Xiaolong Hu , Peng Wang , Yuan Cheng , Hui Wei , Guosheng Fu , Junbo Ge , Hongjun Li , Wenbin Zhang , Binquan Zhou","doi":"10.1016/j.biomaterials.2025.123214","DOIUrl":null,"url":null,"abstract":"<div><div>Heart ischemic injury predominately causes mitochondrial dysfunction, leading to the accumulation of ROS and lactate. The ROS-associated DNA damage response (DDR) contributes to myocardial cell cycle arrest and the inhibition of proliferation, while lactate accumulation is often accompanied by a high risk of acute death. In this study, to restore myocardial metabolism and regenerate the heart, we established a biomimetic peroxisome by loading the Mn<sub>3</sub>O<sub>4</sub> nanozyme into mesenchymal stem cell-derived extracellular vesicles (MSC-EV (Mn@EV)). This setup mimics the peroxidases of peroxisome to catalyze ROS, and inhibit DDR. Next, the Mn@EV was immobilized with lactate oxidase (LOX) after encompassed platelet membrane to obtain biomimetic peroxisome (Mn@LPEV). This mimics the substrate-oxidizing function to detoxify lactate and prevent death. Supported by its biomimetic and lactate-response delivery system, our biomimetic peroxisome effectively targeted deep tissues in the hearts of I/R mice, achieving a 4-fold increase in targeting compared with control vesicles. It maintained myocardial redox homeostasis by scavenging ROS and lactate, inhibiting DDR pathway, promoting myocardial regeneration, reducing acute mortality and fibrosis remodeling, accelerating immunomodulation and angiogenesis, and significantly protecting heart function.</div></div>","PeriodicalId":254,"journal":{"name":"Biomaterials","volume":"319 ","pages":"Article 123214"},"PeriodicalIF":12.9000,"publicationDate":"2025-02-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biomaterials","FirstCategoryId":"5","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0142961225001334","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0
Abstract
Heart ischemic injury predominately causes mitochondrial dysfunction, leading to the accumulation of ROS and lactate. The ROS-associated DNA damage response (DDR) contributes to myocardial cell cycle arrest and the inhibition of proliferation, while lactate accumulation is often accompanied by a high risk of acute death. In this study, to restore myocardial metabolism and regenerate the heart, we established a biomimetic peroxisome by loading the Mn3O4 nanozyme into mesenchymal stem cell-derived extracellular vesicles (MSC-EV (Mn@EV)). This setup mimics the peroxidases of peroxisome to catalyze ROS, and inhibit DDR. Next, the Mn@EV was immobilized with lactate oxidase (LOX) after encompassed platelet membrane to obtain biomimetic peroxisome (Mn@LPEV). This mimics the substrate-oxidizing function to detoxify lactate and prevent death. Supported by its biomimetic and lactate-response delivery system, our biomimetic peroxisome effectively targeted deep tissues in the hearts of I/R mice, achieving a 4-fold increase in targeting compared with control vesicles. It maintained myocardial redox homeostasis by scavenging ROS and lactate, inhibiting DDR pathway, promoting myocardial regeneration, reducing acute mortality and fibrosis remodeling, accelerating immunomodulation and angiogenesis, and significantly protecting heart function.
期刊介绍:
Biomaterials is an international journal covering the science and clinical application of biomaterials. A biomaterial is now defined as a substance that has been engineered to take a form which, alone or as part of a complex system, is used to direct, by control of interactions with components of living systems, the course of any therapeutic or diagnostic procedure. It is the aim of the journal to provide a peer-reviewed forum for the publication of original papers and authoritative review and opinion papers dealing with the most important issues facing the use of biomaterials in clinical practice. The scope of the journal covers the wide range of physical, biological and chemical sciences that underpin the design of biomaterials and the clinical disciplines in which they are used. These sciences include polymer synthesis and characterization, drug and gene vector design, the biology of the host response, immunology and toxicology and self assembly at the nanoscale. Clinical applications include the therapies of medical technology and regenerative medicine in all clinical disciplines, and diagnostic systems that reply on innovative contrast and sensing agents. The journal is relevant to areas such as cancer diagnosis and therapy, implantable devices, drug delivery systems, gene vectors, bionanotechnology and tissue engineering.